Critical limb ischemia: advanced medical therapy.
Systemic atherosclerosis and its risk factors are present in the majority of patients with critical limb ischemia. Aggressive medical therapy is an immediate and necessary part of the work-up and management of these patients and will involve a multidisciplinary approach. Risk stratification based on a patient's current clinical cardiovascular condition is important in determining the most appropriate and safe intervention and will allow both the patient and physician to make an informed decision regarding risk- and cost-benefits of treatment.
Methodist DeBakey Heart & Vascular Center, The Methodist Hospital, Houston, Texas, USA.
Mark G
MG
Davies
D050197:Atherosclerosis / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control; D003952:Diagnostic Imaging / Q000379:methods*; D014943:Global Health; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D015994:Incidence; D007511:Ischemia / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007866:Leg / Q000098:blood supply*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012307:Risk Factors; D016879:Salvage Therapy / Q000379:methods*; D012720:Severity of Illness Index
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D010975:Platelet Aggregation Inhibitors
atherosclerosis; critical limb ischemia; risk assessment; risk modification